{"id":"NCT03855137","sponsor":"Allergan","briefTitle":"Efficacy, Safety, and Tolerability of Atogepant for the Prevention of Chronic Migraine","officialTitle":"A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy, Safety, and Tolerability of Atogepant for the Prevention of Chronic Migraine (Progress)","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2019-03-11","primaryCompletion":"2022-01-20","completion":"2022-01-20","firstPosted":"2019-02-26","resultsPosted":"2023-02-14","lastUpdate":"2023-02-14"},"enrollment":778,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"TRIPLE","primaryPurpose":"TREATMENT"},"conditions":["Chronic Migraine"],"interventions":[{"type":"DRUG","name":"Atogepant 30 mg","otherNames":[]},{"type":"DRUG","name":"Atogepant 60 mg","otherNames":[]},{"type":"DRUG","name":"Placebo","otherNames":[]}],"arms":[{"label":"Placebo","type":"PLACEBO_COMPARATOR"},{"label":"Atogepant 30 mg BID","type":"ACTIVE_COMPARATOR"},{"label":"Atogepant 60 mg QD","type":"ACTIVE_COMPARATOR"}],"summary":"This study evaluated the efficacy, safety and tolerability of atogepant in participants with chronic migraine. This study included a 12-week treatment period.","primaryOutcome":{"measure":"Change From Baseline in Mean Monthly Migraine Days Across 12-Week Treatment Period in mITT Population","timeFrame":"Baseline to Week 12","effectByArm":[{"arm":"Placebo","deltaMin":-4.63,"sd":null},{"arm":"Atogepant 30 mg BID","deltaMin":-7.13,"sd":null},{"arm":"Atogepant 60 mg QD","deltaMin":-7.27,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"0.0001"},{"comp":"OG000 vs OG002","p":"0.0009"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":4,"exclusionCount":4},"locations":{"siteCount":150,"countries":["United States","Australia","Canada","China","Czechia","Denmark","France","Germany","Italy","Japan","Poland","Russia","South Korea","Spain","Sweden","Taiwan","United Kingdom"]},"refs":{"pmids":["40471213","39982105","39715475","39648629","39648617","38924724","37516125","33942560","33142014"],"seeAlso":["http://rxabbvie.com"]},"adverseEventsSummary":{"seriousAny":{"events":3,"n":255},"commonTop":["CONSTIPATION","NAUSEA"]}}